Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis

The use of vitamin K antagonists (VKAs), the cornerstone treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived risk of serious bleeding in Asia. Non-VKA oral anticoagulants (NOACs) are safer alternatives. Here, we evaluate performance differences of NOACs...

Full description

Saved in:
Bibliographic Details
Published in:Stroke
Main Authors: Wang, Kang-Ling, Lip, Gregory Y.H., Lin, Shing-Jong, Chiang, Chern-En
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2015
Subjects:
Original Contributions
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542566/
https://ncbi.nlm.nih.gov/pubmed/26304863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.115.009947
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items